Dato | : | 04.11.2021 kl.21:41 |
Brugernavn | : | iskh |
Hvis der er andre som kunne være interesseret i at høre om Fluoguide positive safety data for deres produkt FG001 for glioblastoma (hjernetumor).
+ at deres første kandidate(r) (FG001) for andre prevalante cancer (bryst/lunge) kan går direkte til test i fase 2.
"FluoGuide initiates preclinical development with FG002":
https://news.cision.com/fluoguide/r/fluoguide-initiates-preclinical-development-with-fg002,c3444331
-----
• 2 patients with cancer located in the brain of a different type than high grade glioma
• Contrast in tumors at higher dose levels is perceived as valuable by the neurosurgeons.
• FG001 can initiate phase 2 (skipping phase 1) clinical development in prevalent indication e.g. lung or beast.
Link:
https://www.youtube.com/watch?v=9WspX7bcHuk&t=209s
Det siger kunderne: